​

Monte Rosa Therapeutics (GLUE) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Monte Rosa Therapeutics Revenue Highlights

Latest Revenue (Y)

$75.62M

Latest Revenue (Q)

$84.93M

Monte Rosa Therapeutics Revenue by Period

Monte Rosa Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$75.62M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Monte Rosa Therapeutics generated $75.62M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Monte Rosa Therapeutics Revenue by Quarter

DateRevenueChange
2025-03-31$84.93M40.04%
2024-12-31$60.65M558.06%
2024-09-30$9.22M96.29%
2024-06-30$4.70M341.26%
2024-03-31$1.06M-87.84%
2023-12-31$8.75M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Monte Rosa Therapeutics generated $84.93M in revenue during Q1 2025, up 40.04% compared to the previous quarter, and up 970.40% compared to the same period a year ago.

Monte Rosa Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ARVNArvinas$263.40M$22.40M
NAGENiagen Bioscience$99.60M$29.13M
GLUEMonte Rosa Therapeutics$75.62M$84.93M
TBPHTheravance Biopharma$64.38M$15.39M
NRIXNurix Therapeutics$54.55M$7.89M
MGTXMeiraGTx$33.28M$1.93M
KROSKeros Therapeutics$3.55M$211.25M
KODKodiak Sciences--
MLTXMoonLake Immunotherapeutics--
ATXSAstria Therapeutics--
ERASErasca--

GLUE Revenue FAQ

What is Monte Rosa Therapeutics’s yearly revenue?

Monte Rosa Therapeutics's yearly revenue for 2024 was $75.62M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. GLUE's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Monte Rosa Therapeutics’s quarterly revenue?

Monte Rosa Therapeutics's quarterly revenue for Q1 2025 was $84.93M, a 40.04% increase from the previous quarter (Q4 2024), and a 7882.05% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $60.65M, a 558.06% increase from the previous quarter (Q3 2024), and a 592.95% increase year-over-year (Q4 2023). GLUE's quarterly revenue for Q3 2024 was $9.22M, a 96.29% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is Monte Rosa Therapeutics’s revenue growth rate?

Monte Rosa Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.